CKD and Muscle Mitochondrial Energetics Baback Roshanravan, MD, MSPH, MS, Bryan Kestenbaum, MD, MS, Jorge Gamboa, MD, PhD, Sharon A. Jubrias, PhD, Ernest Ayers, MSPH, Laura Curtin, BA, Jonathan Himmelfarb, MD, Ian. H. de Boer, MD, MS, Kevin E. Conley, PhD American Journal of Kidney Diseases Volume 68, Issue 4, Pages 658-659 (October 2016) DOI: 10.1053/j.ajkd.2016.05.011 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 Box plots of ATP/O2 ratio (P/O). (A) Participants with CKD versus healthy controls; shown is age-adjusted P for the association. (B) Those with low (≤40) vs high (41-60) eGFRs; shown is age-adjusted P for the continuous association of eGFR with P/O. American Journal of Kidney Diseases 2016 68, 658-659DOI: (10.1053/j.ajkd.2016.05.011) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions